Other Species / Isoforms
  DOR-1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T161
VKALDFRTPAKAKLI
3 0
DOR-1 (human) VKALDFRTPAKAKLI T161
DOR-1 (mouse) VKALDFRtPAKAKLI T161-p
DOR-1 (rat) VKALDFRtPAKAKLI T161-p
T211-p
SPSWYWDtVtKICVF
0 1
DOR-1 (human) SPSWYWDtVtKICVF T211-p
DOR-1 (mouse) SPSWYWDTVTKICVF T211
DOR-1 (rat) SPSWYWDTVTKICVF T211
T213-p
SWYWDtVtKICVFLF
0 1
DOR-1 (human) SWYWDtVtKICVFLF T213-p
DOR-1 (mouse) SWYWDTVTKICVFLF T213
DOR-1 (rat) SWYWDTVTKICVFLF T213
Y318
SSLNPVLYAFLDENF
1 0
DOR-1 (human) SSLNPVLYAFLDENF Y318
DOR-1 (mouse) SSLNPVLyAFLDENF Y318-p
DOR-1 (rat) SSLNPVLYAFLDENF Y318
S344
CGRPDPSSFSRAREA
1 0
DOR-1 (human) CGRPDPSSFSRAREA S344
DOR-1 (mouse) CGRQEPGsLRRPRQA S344-p
DOR-1 (rat) CGGQEPGSLRRPRQA S344
T352
FSRAREATARERVtA
1 0
DOR-1 (human) FSRAREATARERVtA T352
DOR-1 (mouse) LRRPRQAttRERVtA T352-p
DOR-1 (rat) LRRPRQATARERVTA T352
A353
SRAREATARERVtAC
2 0
DOR-1 (human) SRAREATARERVtAC A353
DOR-1 (mouse) RRPRQAttRERVtAC T353-p
DOR-1 (rat) RRPRQATARERVTAC A353
T358-p
ATARERVtACtPsDG
Upstream
4 0
Treatment
  • AG1478
  • DPDPE
  • EGF
DOR-1 (human) ATARERVtACtPsDG T358-p
DOR-1 (mouse) AttRERVtACtPsDG T358-p
DOR-1 (rat) ATARERVTACTPsDG T358
T361-p
RERVtACtPsDGPGG
Upstream
Downstream
4 1
Effects on Modified Protein
  • receptor inactivation, induced
  • receptor internalization, induced
Putative in vivo kinases:
  • GRK2 (human)
  • GRK3 (human)
Putative upstream phosphatases:
  • PPP1CA (human)
  • PPP1CB (human)
Regulatory protein:
  • GRK5 (human)
  • GRK6 (human)
Treatment
  • AG1478
  • calyculin_A
  • Cmpd101
  • DADLE
  • deltorphin_I
  • deltorphin_II
  • DPDPE
  • EGF
  • morphine
  • naloxone
  • naltrexone
  • naltrindole
  • NKH_477
  • okadaic_acid
  • phorbol_ester
  • siRNA
DOR-1 (human) RERVtACtPsDGPGG T361-p
DOR-1 (mouse) RERVtACtPsDGPGG T361-p
DOR-1 (rat) RERVTACTPsDGPGG T361
S363-p
RVtACtPsDGPGGGA
Upstream
Downstream
12 1
Effects on Modified Protein
  • receptor desensitization, altered
  • receptor inactivation, induced
  • receptor internalization, altered
  • receptor internalization, induced
Putative in vivo kinases:
  • GRK2 (human)
  • GRK3 (human)
Putative upstream phosphatases:
  • PPP1CA (human)
  • PPP1CB (human)
Regulatory protein:
  • GRK5 (human)
  • GRK6 (human)
Treatment
  • AG1478
  • bisindolylmaleimide
  • BW373U86
  • calyculin_A
  • Cmpd101
  • DADLE
  • deltorphin_I
  • deltorphin_II
  • DPDPE
  • EGF
  • etorphine
  • fentanyl
  • morphine
  • naloxone
  • naltrexone
  • naltrindole
  • NKH_477
  • okadaic_acid
  • OMI
  • phorbol_ester
  • PTX
  • siRNA
  • TAN-67
DOR-1 (human) RVtACtPsDGPGGGA S363-p
DOR-1 (mouse) RVtACtPsDGPGGGA S363-p
DOR-1 (rat) RVTACTPsDGPGGGA S363-p